Vaxcell-Bio Therapeutics Co., Ltd. (323990.KQ)

KRW 10440.0

(-2.61%)

Annual Balance Sheets

(In KRW)
Breakdown 2023 2022 2021 2020 2019
Total Assets 84.98 Billion 24.16 Billion 31.27 Billion 35.49 Billion 10.03 Billion
Total Current Assets 51.22 Billion 20.89 Billion 28.19 Billion 19.18 Billion 8.31 Billion
Cash And Short Term Investments 50.04 Billion 20.39 Billion 27.3 Billion 18.9 Billion 8.07 Billion
Cash and Cash Equivalents 9.04 Billion 389.66 Million 2.3 Billion 9.9 Billion 4.07 Billion
Short Term Investments 41 Billion 20 Billion 25 Billion 9 Billion 4 Billion
Net Receivables 1.08 Billion - - - -
Inventory 96.73 Million - - - -
Other Current Assets -240.00 -1200.00 -910.00 -50.00 242.86 Million
Total Non-Current Assets 33.75 Billion 3.26 Billion 3.07 Billion 16.31 Billion 10.00
Net PPE 2.67 Billion 2.54 Billion 2.8 Billion 1.14 Billion 1.55 Billion
Good Will And Intangible Assets 206.64 Million 229.45 Million 147.62 Million 68.81 Million 77.47 Million
Good Will - - - - -
Intangible Assets 206.64 Million 229.45 Million 147.62 Million 68.81 Million 77.47 Million
Long-Term Investments -10.17 Billion -19.57 Billion -24.89 Billion 6.1 Billion -380.00
Tax Assets 41.04 Billion 20.06 Billion 25.01 Billion - -1.63 Billion
Other Non Current Assets 370.00 610.00 -630.00 9 Billion 10.00
Other Assets 10.00 - - - 1.71 Billion
Total Liabilities 1.48 Billion 835.77 Million 1.19 Billion 830.09 Million 964.46 Million
Total Current Liabilities 924.14 Million 307.04 Million 392.3 Million 594.18 Million 425.72 Million
Account Payables - - - - -
Tax Payables - - - - -
Short Term Debt 216.89 Million 46.51 Million 183.04 Million 186.35 Million -
Deferred Revenue - - - - -
Other Current Liabilities 707.24 Million 260.52 Million 209.25 Million 407.82 Million 425.72 Million
Total Non Current Liabilities 562.78 Million 528.73 Million 803.67 Million 235.9 Million 538.73 Million
Long-Term Debt 144.33 Million 58.72 Million 37.38 Million 152.75 Million 300.63 Million
Deferred Revenue Non Current - - - - -
Deferred Tax Liabilities Non Current - - - - -
Other Non Current Liabilities 418.45 Million 470.01 Million 766.28 Million 83.15 Million 238.1 Million
Other Liabilities 10.00 -150.00 10.00 - -
Total Equity 83.49 Billion 23.32 Billion 30.08 Billion 34.66 Billion 9.07 Billion
Stock Holders Equity 83.49 Billion 23.32 Billion 30.08 Billion 34.66 Billion 9.07 Billion
Common Stock 11.49 Billion 7.61 Billion 7.61 Billion 3.76 Billion 3.25 Billion
Retained Earnings -43.53 Billion -33.38 Billion -26.5 Billion -21.28 Billion -17.35 Billion
Accumulated other comprehensive income 447.51 Million 210.35 Million 85.39 Million 280.13 Million 121.16 Million
Common Stock Equity 83.49 Billion 23.32 Billion 30.08 Billion 34.66 Billion 9.07 Billion
Capital Lease Obligation 361.23 Million 105.23 Million 220.43 Million 339.11 Million 463.62 Million
Total Investments 30.82 Billion 431.15 Million 109.88 Million 15.1 Billion 3.99 Billion
Total Debt 361.23 Million 105.23 Million 220.43 Million 339.11 Million 300.63 Million
Net Debt -8.68 Billion -284.42 Million -2.08 Billion -9.56 Billion -3.77 Billion

Balance Sheet Charts